273 related articles for article (PubMed ID: 31744190)
1. NF-YA Overexpression in Lung Cancer: LUSC.
Bezzecchi E; Ronzio M; Dolfini D; Mantovani R
Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31744190
[TBL] [Abstract][Full Text] [Related]
2. NF-YA Overexpression in Lung Cancer: LUAD.
Bezzecchi E; Ronzio M; Semeghini V; Andrioletti V; Mantovani R; Dolfini D
Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32075093
[TBL] [Abstract][Full Text] [Related]
3. NF-Y Subunits Overexpression in HNSCC.
Bezzecchi E; Bernardini A; Ronzio M; Miccolo C; Chiocca S; Dolfini D; Mantovani R
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34208636
[TBL] [Abstract][Full Text] [Related]
4. Overexpression and alternative splicing of NF-YA in breast cancer.
Dolfini D; Andrioletti V; Mantovani R
Sci Rep; 2019 Sep; 9(1):12955. PubMed ID: 31506469
[TBL] [Abstract][Full Text] [Related]
5. NF-Y subunits overexpression in gastric adenocarcinomas (STAD).
Gallo A; Ronzio M; Bezzecchi E; Mantovani R; Dolfini D
Sci Rep; 2021 Dec; 11(1):23764. PubMed ID: 34887475
[TBL] [Abstract][Full Text] [Related]
6. Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients.
Belluti S; Semeghini V; Rigillo G; Ronzio M; Benati D; Torricelli F; Reggiani Bonetti L; Carnevale G; Grisendi G; Ciarrocchi A; Dominici M; Recchia A; Dolfini D; Imbriano C
J Exp Clin Cancer Res; 2021 Nov; 40(1):362. PubMed ID: 34782004
[TBL] [Abstract][Full Text] [Related]
7. NF-Y Overexpression in Liver Hepatocellular Carcinoma (HCC).
Bezzecchi E; Ronzio M; Mantovani R; Dolfini D
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33271832
[TBL] [Abstract][Full Text] [Related]
8. NF-YAl drives EMT in Claudin
Londero M; Gallo A; Cattaneo C; Ghilardi A; Ronzio M; Del Giacco L; Mantovani R; Dolfini D
Cell Death Dis; 2023 Jan; 14(1):65. PubMed ID: 36707502
[TBL] [Abstract][Full Text] [Related]
9. NF-YA splice variants have different roles on muscle differentiation.
Basile V; Baruffaldi F; Dolfini D; Belluti S; Benatti P; Ricci L; Artusi V; Tagliafico E; Mantovani R; Molinari S; Imbriano C
Biochim Biophys Acta; 2016 Apr; 1859(4):627-38. PubMed ID: 26921500
[TBL] [Abstract][Full Text] [Related]
10. The Switch from NF-YAl to NF-YAs Isoform Impairs Myotubes Formation.
Libetti D; Bernardini A; Sertic S; Messina G; Dolfini D; Mantovani R
Cells; 2020 Mar; 9(3):. PubMed ID: 32214056
[TBL] [Abstract][Full Text] [Related]
11. The short isoform of NF-YA belongs to the embryonic stem cell transcription factor circuitry.
Dolfini D; Minuzzo M; Pavesi G; Mantovani R
Stem Cells; 2012 Nov; 30(11):2450-9. PubMed ID: 22969033
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the Role and Regulation Mechanism of hsa-miR-147b in Lung Squamous Cell Carcinoma Based on The Cancer Genome Atlas Database.
Ke D; Guo Q; Fan TY; Xiao X
Cancer Biother Radiopharm; 2021 Apr; 36(3):280-291. PubMed ID: 33112657
[No Abstract] [Full Text] [Related]
13. Discovery, characterization and potential roles of a novel NF-YAx splice variant in human neuroblastoma.
Cappabianca L; Farina AR; Di Marcotullio L; Infante P; De Simone D; Sebastiano M; Mackay AR
J Exp Clin Cancer Res; 2019 Dec; 38(1):482. PubMed ID: 31805994
[TBL] [Abstract][Full Text] [Related]
14. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY
World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946
[TBL] [Abstract][Full Text] [Related]
15. Immune signature of T follicular helper cells predicts clinical prognostic and therapeutic impact in lung squamous cell carcinoma.
Xu F; Zhang H; Chen J; Lin L; Chen Y
Int Immunopharmacol; 2020 Apr; 81():105932. PubMed ID: 31836430
[TBL] [Abstract][Full Text] [Related]
16. Prognostic alternative mRNA splicing signature in non-small cell lung cancer.
Li Y; Sun N; Lu Z; Sun S; Huang J; Chen Z; He J
Cancer Lett; 2017 May; 393():40-51. PubMed ID: 28223168
[TBL] [Abstract][Full Text] [Related]
17. Differential
Lin S; Tian C; Li J; Liu B; Ma T; Chen K; Gong W; Wang JM; Huang J
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33786615
[TBL] [Abstract][Full Text] [Related]
18. The NF-Y splicing signature controls hybrid EMT and ECM-related pathways to promote aggressiveness of colon cancer.
Rigillo G; Belluti S; Campani V; Ragazzini G; Ronzio M; Miserocchi G; Bighi B; Cuoghi L; Mularoni V; Zappavigna V; Dolfini D; Mercatali L; Alessandrini A; Imbriano C
Cancer Lett; 2023 Jul; 567():216262. PubMed ID: 37307894
[TBL] [Abstract][Full Text] [Related]
19. Increased IR-A/IR-B ratio in non-small cell lung cancers associates with lower epithelial-mesenchymal transition signature and longer survival in squamous cell lung carcinoma.
Jiang L; Zhu W; Streicher K; Morehouse C; Brohawn P; Ge X; Dong Z; Yin X; Zhu G; Gu Y; Ranade K; Higgs BW; Yao Y; Huang J
BMC Cancer; 2014 Feb; 14():131. PubMed ID: 24571613
[TBL] [Abstract][Full Text] [Related]
20. The CCAAT box binding transcription factor, nuclear factor-Y (NF-Y) regulates transcription of human aldo-keto reductase 1C1 (AKR1C1) gene.
Pallai R; Simpkins H; Chen J; Parekh HK
Gene; 2010 Jul; 459(1-2):11-23. PubMed ID: 20338228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
